GlassScriptPhysician profile
Michelle Hogue
NPI 1396424743
$5,478.43
in general payments reported to CMS, 2019-2025
14 companies · $2,881 in 2025
The $2,881 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,780 · 2024: $818 · 2025: $2,881.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,716 · Travel and Lodging: $1,763.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,715.82 |
| Travel and Lodging | $1,762.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $2,873.00 | 2023-2025 | Evoke, Evoke Scs |
| Boston Scientific Corporation | $1,956.25 | 2023-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Vertos Medical, INC. | $142.69 | 2023-2024 | Mild Device Kit |
| Spr Therapeutics, INC | $106.71 | 2023-2024 | Sprint Pns System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $87.09 | 2024-2025 | Relistor |
| Collegium Pharmaceutical, INC. | $61.70 | 2024-2025 | Belbuca |
| Bioventus LLC | $60.45 | 2023-2025 | Xcell, Stimrouter Implantable Kit, Durolane |
| Painteq LLC | $43.33 | 2023 | Painteq |
| Vertex Pharmaceuticals Incorporated | $37.53 | 2025 | |
| Zimmer Biomet Holdings, INC. | $24.59 | 2023 | Gps III Platelet Concentration System |
| Medtronic, INC. | $24.30 | 2024 | Intellis Adaptivestim |
| Abbvie INC. | $23.81 | 2025 | |
| Averitas Pharma INC. | $21.19 | 2023 | Qutenza |
| Idorsia Pharmaceuticals US INC | $15.79 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Hogue listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.